SCHEMBL891513

SCHEMBL891513

O=C(O)/C=C\C(=O)CC(=O)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
EGLN1 Q9GZT9 2/20 0.50
TP53 P04637 1/20 0.50
EGLN3 Q9H6Z9 1/20 0.50
HAO1 Q9UJM8 2/20 0.48
HCAR2 Q8TDS4 3/20 0.40
OR51E2 Q9H255 2/20 0.36
GABRR1 P24046 2/20 0.36
GABRR2 P28476 2/20 0.36
BLM P54132 2/20 0.36
LMNA P02545 2/20 0.36
GABRR3 A8MPY1 1/20 0.36
APEX1 P27695 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 1/20 0.36
PTPN1 P18031 1/20 0.34
ERCC5 P28715 1/20 0.34
FEN1 P39748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1332598 1.00 TSHR (0.50) TSHREGLN1TP53EGLN3HAO1
SCHEMBL23361428 1.00 TSHR (0.50) TSHREGLN1TP53EGLN3HAO1
SCHEMBL12568561 0.88 TSHR (0.64) TSHREGLN1TP53EGLN3HCAR2
SCHEMBL2780997 0.80 TSHR (0.53) TSHREGLN1TP53EGLN3HCAR2
SCHEMBL1225122 0.80 TSHR (0.53) TSHREGLN1TP53EGLN3HCAR2
SCHEMBL2780998 0.80 TSHR (0.53) TSHREGLN1TP53EGLN3HCAR2
SCHEMBL1082038 0.77 ALOX15 (0.52) TSHREGLN1TP53EGLN3HAO1
SCHEMBL10071355 0.76 TSHR (0.47) TSHREGLN1TP53EGLN3HCAR2
SCHEMBL28089517 0.74 HAO1 (0.45) TSHREGLN1TP53HAO1OR51E2
Maleylacetoacetate SCHEMBL380205 0.74 TSHR (0.45) TSHREGLN1TP53EGLN3HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12162977-B2 Blocked polyisocyanate crosslinking agent, its preparation method and a coating composition comprising the same BASF COATINGS GMBH (DE) 2024-12-10 US claimed
US-20220389153-A1 A BLOCKED POLYISOCYANATE CROSSLINKING AGENT, ITS PREPARATION METHOD AND A COATING COMPOSITION COMPRISING THE SAME BASF COATINGS GMBH (DE) 2022-12-08 US claimed
EP-4058500-A1 A BLOCKED POLYISOCYANATE CROSSLINKING AGENT, ITS PREPARATION METHOD AND A COATING COMPOSITION COMPRISING THE SAME BASF Coatings GmbH (DE) 2022-09-21 EP claimed
WO-2021094237-A1 A BLOCKED POLYISOCYANATE CROSSLINKING AGENT, ITS PREPARATION METHOD AND A COATING COMPOSITION COMPRISING THE SAME BASF COATINGS GMBH (DE) 2021-05-20 WO claimed
US-20180237813-A1 METHOD FOR PRODUCING AROMATIC COMPOUND AND DERIVATIVE THEREOF RIKEN (JP) 2018-08-23 US claimed
CN-108350472-A Process for producing aromatic compound and derivative thereof 国立研究开发法人理化学研究所 2018-07-31 CN claimed
EP-3342874-A1 METHOD FOR PRODUCING AROMATIC COMPOUND AND DERIVATIVE THEREOF RIKEN (JP) 2018-07-04 EP claimed
CN-1594557-A Construction and use for gentisic acid 1,2-dioxygenase gene engineering bacterium CHINA ACADEMY OF SCIENCES WUHA (CN) 2005-03-16 CN claimed
US-12577526-B2 Massively parallel on-chip construction of synthetic microbial communities THE BROAD INSTITUTE, INC. (US) 2026-03-17 US disclosed
US-20250376656-A1 MASSIVELY PARALLEL ON-CHIP CONSTRUCTION OF SYNTHETIC MICROBIAL COMMUNITIES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2025-12-11 US disclosed
US-12162977-B2 Blocked polyisocyanate crosslinking agent, its preparation method and a coating composition comprising the same BASF COATINGS GMBH (DE) 2024-12-10 US disclosed
US-20230365831-A1 A COATING COMPOSITION, ITS PREPARATION AND USE THEREOF BASF COATINGS GMBH (DE) 2023-11-16 US disclosed
EP-4214261-A1 A COATING COMPOSITION, ITS PREPARATION AND USE THEREOF BASF Coatings GmbH (DE) 2023-07-26 EP disclosed
CN-112375723-B Engineering bacteria for producing maleic acid and construction method and application thereof 北京化工大学 2023-06-27 CN disclosed
US-20070214517-A1 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby CERES, INC. (US) 2007-09-13 US disclosed
US-20060150283-A1 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby ALEXANDROV NICKOLAI 2006-07-06 US disclosed
US-20060048240-A1 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby ALEXANDROV NICKOLAI 2006-03-02 US disclosed
CN-1594557-A Construction and use for gentisic acid 1,2-dioxygenase gene engineering bacterium CHINA ACADEMY OF SCIENCES WUHA (CN) 2005-03-16 CN disclosed
US-6594587-B2 Determination of associations among set of biological elements using algorithm that is capable of generating Steiner tree MONSANTO TECHNOLOGY LLC 2003-07-15 US disclosed
US-20020123847-A1 Method for analyzing biological elements TELEPHONICS CORPORATION 2002-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070214517-A1 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby RNGTT, CPSF1, CPSF6 TSHR 1630/4885EGLN1 4292/4885TP53 676/4885
US-20060048240-A1 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby RNGTT, CPSF1, CPSF6 TSHR 1630/4885EGLN1 4292/4885TP53 676/4885
US-12577526-B2 Massively parallel on-chip construction of synthetic microbial communities STUB1, SAMM50, CD14 TSHR 1704/4885EGLN1 4356/4885TP53 2128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.